Navigation Links
Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program
Date:6/5/2008

SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that it has out-licensed all worldwide rights to its NF-kappa B Decoy (NF-kB Decoy) program, which includes the clinical drug candidate Avrina(TM), to Transcription Factor Therapeutics, Inc. (TFT). NF-kB Transcription Factor Decoy inhibits NF-kappa B, a protein implicated in the inflammatory cascade in diseases such as inflammatory bowel disease (IBD), eczema, rheumatoid arthritis, and asthma.

Under the terms of the agreement, Anesiva will receive an upfront license fee, with additional payments dependent on development and regulatory milestones potentially totaling up to $114 million if two products are commercialized. Anesiva would also be entitled to royalty payments upon successful commercialization of any drug candidate(s). Additional terms were not disclosed. TFT will be responsible for the future development of Avrina(TM), and intellectual property associated with the NF-kB Decoy program will be transferred to TFT.

"Anesiva considers TFT a capable development organization to move this program forward," said John P. McLaughlin, chief executive officer of Anesiva. "With a strong focus on anti-inflammatory transcription factor decoys, we believe that TFT is well positioned to advance the NF-kappa B program, which holds great potential to impact the treatment of inflammatory diseases."

TFT initially plans to take Avrina(TM), a highly potent and selective inhibitor of NF-kappa B, into clinical trials in IBD in 2009. Avrina has shown highly encouraging results in multiple preclinical models of both Crohn's Disease and ulcerative colitis, two forms of IBD. These results have been well received in international sc
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anesiva Announces First Quarter 2008 Financial Results
2. Anesiva Announces First Quarter 2008 Financial Results Conference Call and Webcast
3. Anesiva Announces Expansion of Zingo Agreement in Europe
4. Anesiva Announces New Zingo Marketing and Distribution Agreement
5. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
6. Anesiva Announces March 5, 2008 Presentation at Susquehanna Financial Group Healthcare Conference
7. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
8. Anesiva Appoints Daniel Janney to Board of Directors
9. Anesiva Announces Fourth Quarter and Year End 2007 Financial Results Conference Call and February 2008 Conference Participation
10. Anesiva Announces Completion of Common Stock Offering
11. Anesiva Raises $45 Million in Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Quorum Review IRB, the industry ... large clinical trials called Quick Step™ . The offering ... address the research industry’s need for seamless study start-up with ... available for studies planning 50 or more North American investigator ... North American site count of 80 or more. Qualifying studies ...
(Date:7/22/2014)... Angeles, CA (PRWEB) July 22, 2014 ... test solutions with the debut of its fluorescent ... of Clinical Chemistry (AACC) meeting in Chicago, July ... or bench top versions, the HRDR-300 is a ... pending technology to analyze fluorescent lateral flow immunoassays ...
(Date:7/22/2014)... Biofeedback – When a behavioral problem ... medication to best treat it can become a matter ... electroencephalography (EEG) can help predict which medicine will offer ... adverse drug events. , The article “Medication Prediction ... issue of the journal Biofeedback offers evidence that quantitative ...
(Date:7/22/2014)... Dr. Williams says, “Bush has joined the constantly ... greatest health care system in the world is too ... trying to serve the public. Unfortunately, Bush has also ... enormous system that none of them can first describe ... of Open Letters ( http://is.gd/wdU2CM ) provides a critique ...
Breaking Biology Technology:Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2
... 2011  Quammen Health Care Consultants is helping Faith Regional ... a five-year outsourcing agreement. Under the managed IT services ... from strategic vision to vendor relations to day-to-day operations. ... hospitals across the country as a matter of fact ...
... , Dec. 16, 2011 /PRNewswire-Asia/ -- China Sky One ... CSKI ), a leading fully integrated pharmaceutical company ... its wholly-owned subsidiary, Harbin Tian Di Ren Medical Science and ... set up a new company, Harbin Tian Xin Biological Engineering ...
... at the Centre for Quantum Information and Quantum Control at ... the year according to Physics World magazine. , ... technique to the historical two-slit interferometer experiment in which a ... interference pattern on a screen behind. That famous experiment ...
Cached Biology Technology:Quammen Health Care Consultants Takes Over Information Technology Reins at Faith Regional Health Services 2Quammen Health Care Consultants Takes Over Information Technology Reins at Faith Regional Health Services 3China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise 2China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise 3U of Toronto experiment named top breakthrough of 2011 by Physics World 2
(Date:7/22/2014)... 2014, by lightning from a weather system that moved through ... Stokes Fire, Gold Hikes Fire, French Creek Fire and the ... one larger fire. The fires are burning in timber and ... in size. The present fire situation continues to rapidly ... safety is the priority on the Carlton Complex fires. ...
(Date:7/22/2014)... the ,1000 Bull Genomes Project, aims to accelerate breeding ... also improving animal health and welfare. Results of the ... genomes of 234 individual bulls whose direct descendants number ... the journal Nature Genetics . , According to ... reduce or eliminate hereditary diseases and to improve the ...
(Date:7/22/2014)... negative reputation as disease causing agents, some viruses ... help to shape the world we live in ... American Academy of Microbiology. , "Viruses participate in ... on the planet, from contributing to biogeochemical cycles, ... events," states Marilyn Roossinck of Pennsylvania State University, ...
Breaking Biology News(10 mins):Whole-genome sequencing of bulls in key beef and dairy breeds 2Report on viruses looks beyond disease 2
... Barcelona, Spain: Diabetes in men has ... annual conference of the European Society of Human Reproduction and ... University, Belfast, UK, said that, despite the prevailing view that ... group had shown that diabetes caused DNA damage in sperm. ...
... (July 8, 2008) Scientists announced today the discovery ... the Southern Atlantic Ocean,s largest and richest reef system, ... Bahia state. The newly discovered area is ... previously known Abrolhos reef system, one of the world,s ...
... Iowa -- Ground cover may be one workable method to ... predicted to bring. Iowa State University researchers are looking ... between the rows of corn, in production farming. The ... looking beyond the kernel to the entire corn plant for ...
Cached Biology News:Diabetes linked to male infertility; excess sugars in the body have direct effect on sperm quality 2Diabetes linked to male infertility; excess sugars in the body have direct effect on sperm quality 3Scientists discover new reefs teeming with marine life in Brazil 2Iowa State researchers study ground cover to reduce impact of biomass harvest 2Iowa State researchers study ground cover to reduce impact of biomass harvest 3Iowa State researchers study ground cover to reduce impact of biomass harvest 4
Contains L-glutamine....
Contains L-glutamine...
... Clone/PAD: ZMD.358. Immunogen: ... C-terminal region of human mouse ... Reacts with human and mouse ... Human (positive controls: mouse LRP5-pSEC-tag-transfected ...
Replacement Parts for Electrophoresis Apparatus...
Biology Products: